Seeking Alpha: Feeling A Little Better About The Growth/Value Proposition At Medtronic

Med-tech isn't much different than any other sector of the market; when the growth goes, so do the investors. While the widespread slowdowns in multiple key businesses have definitely dented Medtronic's (MDT) recent growth, it's not as though the stock may seem to be an obvious bargain at about three times trailing sales and more than eight times trailing EBITDA.

That said, Medtronic seems to be seeing some signs of life in major units like cardiac rhythm management and cardiology, and the success of recent new product introduction bodes well for some high-profile launches in the coming years. As a balanced growth/value/income play on the healthcare space, Medtronic is looking more interesting as a stock these days.

Please follow this link for more:
Feeling A Little Better About The Growth/Value Proposition At Medtronic